drugset

drugset / Trial / NCT01131091

A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403

NCT01131091 ↗

Phase 1 Completed 30 enrolled Kowa Research Institute, Inc.

Non-randomizedParallel-groupOpen-label

Summary

This is a Phase 1, multicenter, open label, single dose study. A total of 30 subjects are planned (5 groups of 6 subjects each.)

Timeline

Start: 2010-05
Primary completion: 2010-11
Completion: 2010-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Anagliptin	Small molecule	400 mg	—

Indications